Published by Iain Gilbert on 22nd October 2025
(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its chronic rhinosinusitis with nasal polyps treatment, Tezspire, has been approved in the European Union as an add-on therapy with intranasal corticosteroids for adults.
URL: http://www.digitallook.com/dl/news/story/35439166/...